Sanofi (NASDAQ:SNY) Receives Consensus Rating of “Hold” from Brokerages

Shares of Sanofi (NASDAQ:SNY) have earned a consensus recommendation of “Hold” from the five brokerages that are presently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $57.50.

A number of research firms have issued reports on SNY. StockNews.com upgraded Sanofi from a “buy” rating to a “strong-buy” rating in a research note on Thursday. Argus upped their target price on shares of Sanofi from $55.00 to $60.00 and gave the company a “buy” rating in a report on Friday, July 26th.

Institutional Investors Weigh In On Sanofi

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. POM Investment Strategies LLC purchased a new stake in shares of Sanofi in the second quarter worth $25,000. Venturi Wealth Management LLC increased its stake in Sanofi by 163.5% in the 4th quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock worth $27,000 after buying an additional 332 shares in the last quarter. Frazier Financial Advisors LLC bought a new stake in Sanofi during the fourth quarter valued at about $28,000. Register Financial Advisors LLC purchased a new position in shares of Sanofi in the first quarter valued at about $29,000. Finally, Larson Financial Group LLC boosted its stake in shares of Sanofi by 480.8% in the first quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock worth $29,000 after acquiring an additional 500 shares during the period. Institutional investors own 10.04% of the company’s stock.

Sanofi Stock Down 0.3 %

Shares of Sanofi stock opened at $51.66 on Friday. Sanofi has a twelve month low of $42.63 and a twelve month high of $55.72. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The company’s 50 day moving average is $49.42 and its 200 day moving average is $48.70. The company has a market cap of $130.84 billion, a price-to-earnings ratio of 25.96, a price-to-earnings-growth ratio of 1.50 and a beta of 0.59.

Sanofi (NASDAQ:SNY) last released its quarterly earnings results on Thursday, July 25th. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.88 by $0.05. Sanofi had a return on equity of 26.29% and a net margin of 9.60%. The firm had revenue of $10.75 billion for the quarter, compared to the consensus estimate of $16.86 billion. During the same period last year, the business posted $0.95 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. Research analysts anticipate that Sanofi will post 4.16 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.